Order Article Reprints

De Simone M, Vaira M, Argenziano M, Berchialla P, Pisacane A, Cinquegrana A, Cavalli R, Borsano A, Robella M. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Oxaliplatin, Cisplatin, and Doxorubicin in Patients with Peritoneal Carcinomatosis: An Open-Label, Single-Arm, Phase II Clinical Trial. Biomedicines. 2020; 8(5):102. https://doi.org/10.3390/biomedicines8050102

De Simone, Michele, Marco Vaira, Monica Argenziano, Paola Berchialla, Alberto Pisacane, Armando Cinquegrana, Roberta Cavalli, Alice Borsano, and Manuela Robella. 2020. "Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Oxaliplatin, Cisplatin, and Doxorubicin in Patients with Peritoneal Carcinomatosis: An Open-Label, Single-Arm, Phase II Clinical Trial" Biomedicines 8, no. 5: 102. https://doi.org/10.3390/biomedicines8050102

De Simone, M., Vaira, M., Argenziano, M., Berchialla, P., Pisacane, A., Cinquegrana, A., Cavalli, R., Borsano, A., & Robella, M. (2020). Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Oxaliplatin, Cisplatin, and Doxorubicin in Patients with Peritoneal Carcinomatosis: An Open-Label, Single-Arm, Phase II Clinical Trial. Biomedicines, 8(5), 102. https://doi.org/10.3390/biomedicines8050102